| 产品描述: | TDI-11861 is an orally active soluble sAC inhibitor optimized and designed based on TDI-10229 , with an IC50 of 3.3 nM and a KD of 1.4 nM. TDI-11861 has advantages such as high affinity, slow dissociation, and good pharmacokinetics. TDI-11861 can be used for research on male contraception and related sAC pharmacology. |
| 体外研究: |
在雄性 CD-1 小鼠中的药代动力学分析[1] |
| 体内研究: |
TDI-11861 (5.5 nM; 15 min) 在大鼠 4-4 细胞中抑制 sAC 介导的 cAMP 积累。 |
| 保存条件: |
-80°C 6个月;-20°C 1个月 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.021 ml |
10.103 ml |
20.205 ml |
| 5 mM |
0.404 ml |
2.021 ml |
4.041 ml |
| 10 mM |
0.202 ml |
1.01 ml |
2.021 ml |
| 50 mM |
0.04 ml |
0.202 ml |
0.404 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |